Castleman's disease is a rare lymphoproliferative disorder characterized by an abnormal growth of lymphoid tissue. It encompasses several forms, including unicentric Castleman disease (UCD ...
GlobalData on MSN4d
Atara’s T cell programmes hit with clinical hold after third-party site woesThe FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for ...
On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...
The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a ...
Tabelecleucel, an allogeneic, EBV-specific T-cell immunotherapy, works by targeting and eliminating EBV-infected cells.
Halsey is reflecting on their two year transformation following their health diagnosis. “Hey. I just wanna say; I looked and ...
The FDA has issued a complete response letter to the biologics license application seeking the approval of tabelecleucel for ...
After receiving a complete response letter last week, the other shoe has dropped for Atara Biotherapeutics and its pipeline ...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr ...
Atara Therapeutics’ Ebvallo, already marketed in Europe for a transplant-related blood cancer, will not hit the U.S. market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback